RAF1 and gastric cancer: In summary, we revealed that DHCE can suppress proliferation, induce apoptosis and G2/M phase arrest in gastric cancer cells, and suppress the migration and invasion of gastric cancer cells by targeting the Ras/Raf/ERK/MMP9 pathway.